These peptides, derived from or designed to target pineal gland tissue, aim to rehabilitate the organ responsible for your sleep architecture instead of merely compensating for its decline
Aging Cell 19:e13235
Lavisse S, Goutal S, Wimberley C, Tonietto M, Bottlaender M, Gervais P, et al
Dysesthesia: Retatrutide's Unique Issue Dysesthesia (abnormal touch sensations) affects 1 in 5 retatrutide patients at highest dose
Evaluation of metabolically stabilized angiotensin IV analogs as procognitive/antidementia agents McCoy AT, Benoist CC, Wright JW, et al
This is when the provider assesses protocol response and makes any dose or frequency adjustments based on observed outcomes and patient feedback